Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

3.15
BATS BZX Real-Time Price
As of 3:36pm ET
 +0.15 / +5.00%
Today’s Change
1.96
Today|||52-Week Range
4.55
+5.00%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.00
Today’s open3.00
Day’s range3.00 - 3.20
Volume52,428
Average volume (3 months)302,286
Market cap$98.3M
Dividend yield--
Data as of 3:36pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+32.42%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.25+4.59%
ACRXAcelRx Pharmaceutica...+0.05+2.33%
ORMPOramed Pharmaceutica...-0.01-0.13%
ZFGNZafgen Inc-0.10-2.70%
Data as of 3:35pm ET, 06/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts